Adaptyv Biosystems raised €34M in a Series A round in Aug 2026. The company is based in Switzerland. Investors in the round: ACE Ventures, ByFounders, Highland Europe and 1 other. Data as of 27 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
